Back
Nuveen CA Select Tax Free Income Port Vs. Viking Therapeutics Industry Stock Comparison
Sell
44
NXC
Nuveen CA Select Tax Free Income Port
Last Price:
13.99
Seasonality Move:
-2.11%
Buy
80
VKTX
Viking Therapeutics
Last Price:
64.47
Seasonality Move:
18.2%
Sell
44
Nuveen CA Select Tax Free Income Port (NXC)
is a Sell
Is Nuveen CA Select Tax Free Income Port a Buy, Sell or Hold?
- The current Nuveen CA Select Tax Free Income Port [NXC] share price is $13.96. The Score for NXC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- NXC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $64.46. The Score for VKTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NXC Stock Price Chart
What is Nuveen CA Select Tax Free Income Port's stock price today?
-
The Nuveen CA Select Tax Free Income Port share price today is $13.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NXC is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $64.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight buying pressure.
NXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 60.92 | Buy |
| Chaikin Money Flow: | -1040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.67 - 13.91) | Buy |
| Bollinger Bands (100): | (13.03 - 13.71) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.38 | Buy |
| Relative Strength Index (14 RSI): | 56.7 | Buy |
| Chaikin Money Flow: | 155400 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.21 - 65.49) | Buy |
| Bollinger Bands (100): | (51.86 - 68.76) | Buy |
NXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.92 | Buy |
| 20-day SMA: | 13.81 | Buy |
| 50-day SMA: | 13.61 | Buy |
| 200-day SMA: | 13.22 | Buy |
| 8-day EMA: | 13.9 | Buy |
| 20-day EMA: | 13.82 | Buy |
| 50-day EMA: | 13.64 | Buy |
| 200-day EMA: | 13.29 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.79 | Buy |
| 20-day SMA: | 61.45 | Buy |
| 50-day SMA: | 58.5 | Buy |
| 200-day SMA: | 52.22 | Buy |
| 8-day EMA: | 62.78 | Buy |
| 20-day EMA: | 61.14 | Buy |
| 50-day EMA: | 59.58 | Buy |
| 200-day EMA: | 51.11 | Buy |
Nuveen CA Select Tax Free Income Port Earnings Growth & NXC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Nuveen CA Select Tax Free Income Port Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||